Product

Company

Clareo Health | Omics Techniques in Fatty Liver Disease

NCT05907408·1 site·ClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Universidade Federal do Rio de Janeiro

Age

18–75

Sex

ALL

Healthy volunteers

Not accepted

Metabolic syndrome
Liver steatosis detected on transient hepatic elastography performed in the last 12 months
Steatosis with or without fibrosis confirmed histologically in a liver biopsy performed in the last 12 months

The record

StatusUnknown

PhaseNo phase

Taking part10

StartedJul 2023

UpdatedJun 18, 2023

Conditions

Where1